Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Translational Cancer Research|July 15, 2022
Gastroparesis as a significant gastrointestinal adverse event during intensive chemotherapy for solid caner: a case reportTomohiro Nakayama, Koji Haratani, Takashi Kurosaki, et al.
Investigational New Drugs|August 31, 2021
Successful treatment of a case of hormone receptor-positive metastatic extramammary Paget disease with tamoxifenKohsuke Isomoto, Koji Haratani, Satomi Watanabe, et al.
The Oncologist|July 29, 2025
Clinical and molecular landscape of metastatic extramammary Paget's diseaseSatomi Watanabe, Koji Haratani, Tomohiro Nakayama, et al.
Rinsho Shinkeigaku = Clinical Neurology|July 1, 2016
A case of hemifacial paresis in a patient with Lyme neuroborreliosis treated with antibiotics in whom Borrelia meningitis developedHisao Shimizu, Koji Haratani, Masayuki Miyazaki, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
miR126-mediated impaired vascular integrity in Rett syndromeTatsuya Osaki, Zhengpeng Wan, Koji Haratani, et al.
Oncotarget|May 17, 2018
Clinical characteristics of non-small cell lung cancer harboring mutations in exon 20 of EGFR or HER2Masayuki Takeda, Kazuko Sakai, Hidetoshi Hayashi, et al.
Frontiers in Oncology|September 2, 2022
Contribution of MMP14-expressing cancer-associated fibroblasts in the tumor immune microenvironment to progression of colorectal cancerYusuke Makutani, Hisato Kawakami, Takahiro Tsujikawa, et al.
Molecular Psychiatry|February 18, 2026
miR126-mediated alteration of vascular integrity in Rett syndromeTatsuya Osaki, Zhengpeng Wan, Koji Haratani, et al.
Cancer Chemotherapy and Pharmacology|February 2, 2017
Phase 1 study of new formulation of patritumab (U3-1287) Process 2, a fully human anti-HER3 monoclonal antibody in combination with erlotinib in Japanese patients with advanced non-small cell lung cancerToshio Shimizu, Kimio Yonesaka, Hidetoshi Hayashi, et al.
Lung Cancer (Amsterdam, Netherlands)|November 12, 2019
Impact of coexisting gene mutations in EGFR-mutated non-small cell lung cancer before treatment on EGFR T790M mutation status after EGFR-TKIsMasayuki Takeda, Kazuko Sakai, Hidetoshi Hayashi, et al.
Pageof 6